Key facts
- This page summarizes Ezequiel Simmermacher's Form 4 filing for Bioceres Crop Solutions Corp. (BIOX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Aug 2026, 14:44.
Ezequiel Simmermacher - 03 Aug 2026 Form 4 Insider Report for Bioceres Crop Solutions Corp. (BIOX)
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2026, 14:44:47 UTC
- Prior SEC filing
- 11 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ezequiel Simmermacher
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ezequiel Simmermacher filed Form 4 for Bioceres Crop Solutions Corp. (BIOX) on 04 Aug 2026.
Change
- Previous filing in this sequence was filed on 11 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002125915
Primary reporting owner
Simmermacher Ezequiel
- Relationship
- CFO
- Address
- CALLE 64 S/N, PILAR, ARGENTINA
- Signature
- /s/ Ezequiel Simmermacher
- Signature date
- 04 Aug 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIOX
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +375,000
- Change %
- Price
- $0.000000*
- Shares after
- 375,000
- Date
- 03 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 375,000
- Exercise price
- $1.45
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These options were granted on August 3, 2026, pursuant to the terms of a stock option agreement under the 2023 Omnibus Equity Incentive Plan. The options vest annually in three equal installments commencing June 30, 2026, subject to vesting conditions.